Characterization of a human cell line stably over-expressing the candidate oncogene, dual specificity phosphatase 12

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Cain, Erica L ^a   Braun, Sterling E ^a   Beeser, Alexander ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA1 INTEGRIN; DUAL SPECIFICITY PHOSPHATASE; DUAL SPECIFICITY PHOSPHATASE 12; GREEN FLUORESCENT PROTEIN; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG; MESSENGER RNA;

ANCHORAGE INDEPENDENT GROWTH; APOPTOSIS; ARTICLE; CARCINOGENICITY; CELL MOTILITY; CELL ONCOGENE; CELL PROLIFERATION; CELL PROTECTION; CELL TRANSFORMATION; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE ISOLATION; GENE OVEREXPRESSION; GENETIC STABILITY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PROTO ONCOGENE; STABLE EXPRESSION; UPREGULATION; CELL LINE; CELL MOTION; ELECTRON MICROSCOPY; GENETICS; METABOLISM; ONCOGENE; PHYSIOLOGY;

APOPTOSIS; CELL LINE; CELL MOVEMENT; DUAL-SPECIFICITY PHOSPHATASES; HUMANS; MICROSCOPY, ELECTRON; ONCOGENES; RNA, MESSENGER;

EID: 79955426456     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018677     Document Type: Article

References (39)

1. Kresse SH, Berner JM, Meza-Zepeda LA, Gregory SG, Kuo WL, et al. (2005) Mapping and characterization of the amplicon near APOA2 in 1q23 in human sarcomas by FISH and array CGH. Mol Cancer 4: 39.
2. Ma Y, Hendershot LM, (2004) The role of the unfolded protein response in tumour develepoment: Friend or foe? Nat Rev Cancer 4: 966-977.
3. Gratias S, Schuler A, Hitpass LK, Stephan H, Rieder H, et al. (2005) Genomic gains on chromosome 1q in retinoblastoma: Consequences on gene expression and association with clinical manifestation. Int J Cancer 116: 555-563.
4. Mendrzyk F, Korshunov A, Benner A, Toedt G, Pfister S, et al. (2006) Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma. Clin Cancer Res 12: 2070-2079.
5. Hirai M, Yoshida S, Kashiwagi H, Kawamura T, Ishikawa T, et al. (1999) 1q23 gain is associated with progressive neuroblastoma resistant to aggressive treatment. Genes Chromosomes Cancer 25: 261-269.
6. Guan K, Broyles SS, Dixon JE, (1991) A Tyr/Ser protein phosphatase encoded by vaccinia virus. Nature 350: 359-362.
7. Patterson KI, Brummer T, O'Brien PM, Daly RJ, (2009) Dual-specificity phosphatases: Critical regulators with diverse cellular targets. Biochem J 418: 475-489.
8. Pulido R, Hooft van Huijsduijnen R, (2008) Protein tyrosine phosphatases: Dual-specificity phosphatases in health and disease. FEBS 275: 848-866.
9. Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, et al. (1999) Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283: 1544-1548.
10. MacKeigan JP, Murphy LO, Blenis J, (2005) Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance. Nat Cell Biol 7: 591-600.
11. Sharda PR, Bonham CA, Mucaki EJ, Butt Z, Vacratsis PO, (2009) The dual-specificity phosphatase hYVH1 interacts with Hsp70 and prevents heat-shock-induced cell death. Biochem J 418: 391.
12. Guan K, Hakes DJ, Wang Y, Park HD, Cooper TG, et al. (1992) A yeast protein phosphatase related to the vaccinia virus VH1 phosphatase is induced by nitrogen starvation. Proc Natl Acad Sci USA 89: 12175-12179.
13. Beeser AE, Cooper TG, (2000) The dual-specificity protein phosphatase Yvh1p regulates sporulation, growth, and glycogen accumulation independently of catalytic activity in saccharomyces cerevisiae via the cycle AMP-dependent protein kinase cascade. J of Bacto 182: 3517-3528.
14. Muda M, Manning ER, Orth K, Dixon JE, (1999) Identification of the human YVH1 protein-tyrosine phosphatase orthologue reveals a novel zinc binding domain essential for in vivo function. J of Biol Chem 274: 23991-23995.
15. Kemmler S, Occhipiniti L, Veisu M, Panse VG, (2009) Yvh1 is required for a late maturation step in the 60S biogenesis pathway. JCB 186: 863-880.
16. Lo K, Li Z, Wang F, Marcotte EM, Johnson AW, (2009) Ribosome stalk assembly requires the dual-specificity phosphatase Yvh1 for the exchange of Mrt4 with P0. JCB 186: 849-862.
17. Shen C, Gu M, Song C, Miao L, Hu L, et al. (2008) The tumorigenicity diversification in human embryonic kidney 293 cell line cultured in vitro. Biologicals 36: 263-268.
18. Croce CM, (2008) Oncogenes and cancer. N Engl J Med 358: 502-511.
19. Koh DW, Dawson TM, Dawson VL, (2005) Mediation of cell death by poly(ADP-ribose) polymerase-1. Pharmacol Res 52: 5-14.
20. He Q, Montalbano J, Corcoran C, Jin W, Huang Y, et al. (2003) Effect of bax deficiency on death receptor 5 and mitochondrial pathways during endoplasmic reticulum calcium pool depletion-induced apoptosis. Oncogene 22: 2674-2679.
21. Lochter A, Navre M, Werb Z, Bissell MJ, (1999) a1 and a2 integrins mediate invasive activity of mouse mammary carcinoma cells through regulation of stromelysin-1 expression. Mol Biol Cell 10: 271-282.
22. Pozzi A, Moberg PE, Miles LA, Wagne S, Soloway P, et al. (2000) Elevated matrix metalloprotease and angiostatin levels in integrin a1 knockout mice cause reduced tumor vascularization. PNAS 97: 2202-2207.
23. Pozzi A, Wary KK, Giancotti FG, Gardner HA, (1998) Integrin a1b1 mediates a unique collagen-dependent proliferation pathway in vivo. JCB 142: 587-594.
24. Schadendorf D, Fichtner I, Makkil A, Alijagic S, Kiipper M, et al. (1996) Metastatic potential of human melanoma cells in nude mice characterisation of phenotype, cytokine secretion and tumour-associated antigens. Br J Cancer 74: 194-199.
25. Senger DR, Perruzzi CA, Streit M, Koteliansky VE, de Fougerolles AR, et al. (2002) The alpha1beta1 and alpha2beta1 integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration, and tumor angiogenesis. Am J Pathol 160: 195-204.
26. Zhang YW, Vande Woude GF, (2003) HGF/SF-met signaling in the control of branching morphogenesis and invasion. J Cell Biochem 88: 408-417.
27. Martin TA, Jiang WG, (2010) Hepatocyte growth factor and its receptor signalling complex as targets in cancer therapy. Anticancer Agents Med Chem 10: 2-6.
28. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF, (2003) Met, metastasis, motility and more. Nat Rev Mol Cell Biol 4: 915-925.
29. Fukuda T, Ichimura E, Shinozaki T, Sano T, Kashiwabara K, et al. (1998) Coexpression of HGF and c-MET/HGF receptor in human bone and sof tissue tumors. Pathol Int 48: 757-762.
30. Kuhnen C, Tolnay E, Steinau HU, Voss B, Muller KM, (1998) Expression of c-met receptor and hepatocyte growth factor/scatter factor in synovial sarcoma and epithelioid sarcoma. Virchows Arch 432: 337-342.
31. Christensen JG, Burrows J, Salgia R, (2005) c-met as a target for human cancer and characterization of inhibitors for therapeutic intervention. Cancer Lett 225: 1-26.
32. Di Renzo MF, Olivero M, Giacomini A, Porte H, Chastre E, et al. (1995) Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer. Clin Cancer Res 1: 147-154.
33. Rahimi N, Hung W, Tremblay E, Saulnier R, Elliott B, (1998) c-src kinase activity is required for hepatocyte growth factor-induced motility and anchorage-independent growth of mammary carcinoma cells. JBC 273: 33714-33721.
34. Tomida M, Saito T, (2004) The human hepatocyte growth factor (HGF) gene is transcriptionally activated by leukemia inhibitory factor through the stat binding element. Oncogene 23: 679-686.
35. DeoCampo ND, Wilson MR, Trosko JE, (2000) Cooperation of bcl-2 and myc in the neoplastic transformation of normal rat liver epithelial cells is related to the down-regulation of gap junction-mediated intercellular communication. Carcinogenesis 21: 1501-1506.
36. Amstad PA, Liu H, Ichimiya M, Chang S, Berezesky IK, et al. (1997) 1997. bcl-2 enhancement of malignant transformation in mouse epidermal JB6 cells. 20:231-239. Mol Carcinog 20: 231-239.
37. Dai M, Sears R, Lu J, (2007) Feedback regulation of c-myc by ribosomal protein L11. Cell Cycle 6: 2735-2741.
38. Grandori C, Gomez-Roman N, Felton-Edkins ZA, Ngouenet C, Galloway DA, et al. (2005) c-myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nat Cell Biol 7: 310-317.
39. Caunt CJ, Armstrong SP, Rivers CA, Norman MR, McArdle CA, (2008) Spatiotemporal regulation of ERK2 by dual specificity phosphatases. JBC 283: 26612.